
137.89 Delayed Data As of Mar 31 | ![]() Today’s Change | 61.28 Today|||52-Week Range 159.84 | +6.41% Year-to-Date |
Sarepta Therapeutics (SRPT) Down 6.2% Since Last Earnings Report: Can It Rebound? Mar 30 / Zacks.com - Paid Partner Content | Sarepta Therapeutics (SRPT) Soars 7.1%: Is Further Upside Left in the Stock? Mar 21 / Zacks.com - Paid Partner Content |
3 Up-and-Coming Growth Stocks to Buy Right Now Mar 25 / MotleyFool.com - Paid Partner Content |
Previous close | 136.03 |
Today’s open | 136.71 |
Day’s range | 136.71 - 139.19 |
Volume | 40,428 |
Average volume (3 months) | 1,230,343 |
Market cap | $12.1B |
Earnings growth (last year) | -55.90% |
Earnings growth (this year) | +36.05% |
Earnings growth (next 5 years) | +67.30% |
Revenue growth (last year) | +32.93% |
P/E ratio | NM |
Price/Sales | 12.16 |
Price/Book | 31.49 |
Next reporting date | May 3, 2023 |
EPS forecast (this quarter) | -$1.33 |
Annual revenue (last year) | $933.0M |
Annual profit (last year) | -$703.5M |
Net profit margin | -75.40% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |